Comparative Effectiveness of Switching From First-Generation Basal Insulin to Glargine 300 U/ml or Degludec 100 U/ml in Type 1 Diabetes: The RESTORE-1 Study

INTRODUCTION: Following pivotal trials, real-world evidence is important to assess the impact of new drugs in everyday clinical practice. The RESTORE-1 study aimed to compare effectiveness and safety of the second-generation basal insulins (2BI), i.e., insulin glargine 300 U/ml (Gla-300) vs. deglude...

Descripción completa

Detalles Bibliográficos
Autores principales: Laviola, Luigi, Porcellati, Francesca, Bruttomesso, Daniela, Larosa, Monica, Rossi, Maria Chiara, Nicolucci, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846660/
https://www.ncbi.nlm.nih.gov/pubmed/33351177
http://dx.doi.org/10.1007/s13300-020-00982-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846660/
https://www.ncbi.nlm.nih.gov/pubmed/33351177
http://dx.doi.org/10.1007/s13300-020-00982-z

Ejemplares similares